| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | |
|---|
|
| | | IP | CI | | KCl Retard Hausmann ‐ I - T | 40 Dragée(s) | 6.80 | 16.65 | 10 % | | Delayed release tablets: Kalii Chloridum 745.5 mg | Doetsch Grether AG | B / SL | FB | G |
| | | IP | CI | | KCl Retard Hausmann ‐ I - T | 200 Dragée(s) | 28.56 | 47.50 | 10 % | | Delayed release tablets: Kalii Chloridum 745.5 mg | Doetsch Grether AG | B / SL | FB | G |
| | | IP | CI | | Plus Kalium retard | 40 | | 9.00 | k.A. | | Delayed release tablets: Kalii Chloridum 600 mg | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | ● B | FB | G |
| | | IP | CI | | Plus Kalium retard | 200 | | | k.A. | | Delayed release tablets: Kalii Chloridum 600 mg | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | ● B | FB | G |
|
| | | IP | CI | | Kalium Hausmann | 10 Tablet(s) | 4.11 | 13.70 | 10 % | | Effervescent tablets: Kalii Hydrogenocarbonas 1444 mg | Doetsch Grether AG | B / SL | FB | G |
| | | IP | CI | | Kalium Hausmann | 60 Tablet(s) | 19.27 | 37.35 | 10 % | | Effervescent tablets: Kalii Hydrogenocarbonas 1444 mg | Doetsch Grether AG | B / SL | FB | G |
|
| | | IP | | | Kaliumchlorid 14,9 % B.
Braun | 20 x 10 ml | | | k.A. | | Infusion solution: 2 Active Agents | B. Braun Medical SA | B | FB | G |
| | | IP | | | Kaliumchlorid 7,45 % B.
Braun | 20 x 20 ml | | | k.A. | | Infusion solution: 2 Active Agents | B. Braun Medical SA | B | FB | G |
| | | IP | | | Kalium chloratum 15%
Sintetica | 10 1 ampoule(s) à 10 ml | | | k.A. | | Infusion preparation: Kalii Chloridum 150 mg/ml | Sintetica SA | B | FB | G |
| | | IP | | | KCL 7,45% Sintetica,
concentrato per soluzione per
infusione (fiala di 50 ml) | ampoule(s) à 50 ml | | | k.A. | | Concentrate for infusion: 2 Active Agents | Sintetica SA | B | FB | G |
| | | IP | | | KCL 7,45% Sintetica | ampoule(s) à 20 ml | | | k.A. | | concentrato per soluzione per infusione: Kalii Chloridum 74.5 mg/ml | Sintetica SA | B | FB | G |
| | | IP | | | KCL 7,45% Sintetica,
concentrato per soluzione per
infusione (fiala di 50 ml) | 10 1 ampoule(s) à 50 ml | | | k.A. | | Concentrate for infusion: 2 Active Agents | Sintetica SA | B | FB | G |
| | | IP | | | Kaliumchlorid Bichsel 15 % | 10 1 Vial(s) à 50 ml | | | k.A. | | Konzentrat zur Herstellung einer Infusionslösung (Vial): 3 Active Agents | Laboratorium Dr. G.
Bichsel AG | B | FB | G |
| | | IP | | | Kaliumchlorid 7.5 % | 10 1 Vial(s) à 50 ml | | | k.A. | | Konzentrat zur Herstellung einer Infusionslösung (Vial): 3 Active Agents | Laboratorium Dr. G.
Bichsel AG | B | FB | G |
| | | IP | | | KCL 7,45% Sintetica | 10 1 ampoule(s) à 20 ml | | | k.A. | | concentrato per soluzione per infusione: Kalii Chloridum 74.5 mg/ml | Sintetica SA | B | FB | G |
|
| | | IP | | | Prismasol 4 mmol/l
Potassium | 2 x 5000 ml | | | k.A. | | Hemofiltration and hemodialysis solution: 3 Active Agents
Hemofiltration and hemodialysis solution: 3 Active Agents | Vantive GmbH | B | FB | G |
| | | IP | | | Hemosol B0 | 2 x 5000 ml | | | k.A. | | Hemofiltration solution: 2 Active Agents
Hemofiltration solution: 3 Active Agents | Vantive GmbH | B | FB | G |
| | | IP | | | Regiocit | 2 x 5000 ml | | | k.A. | | Hemofiltration solution: 2 Active Agents | Vantive GmbH | B | FB | G |
| | | IP | | | Biphozyl | 2 x 5000 ml | | | k.A. | | Lösung für Hämodialyse und Hämofiltration: 2 Active Agents
Lösung für Hämodialyse und Hämofiltration: 4 Active Agents | Vantive GmbH | B | FB | G |
| | | IP | | | Multibic Kaliumfrei | 2 x 5000 ml | | | k.A. | | Hemofiltration solution: 6 Active Agents
Hemofiltration solution: 4 Active Agents
Hemofiltration solution: 2 Active Agents | Fresenius Medical
Care (Schweiz) AG | B | FB | G |
| | | IP | | | Multibic 3 mmol/l Kalium | 2 x 5000 ml | | | k.A. | | Hemofiltration solution: 7 Active Agents
Hemofiltration solution: 5 Active Agents
Hemofiltration solution: 2 Active Agents | Fresenius Medical
Care (Schweiz) AG | B | FB | G |
| | | IP | | | Multibic 2 mmol/l Kalium | 2 x 5000 ml | | | k.A. | | Hemofiltration solution: 7 Active Agents
Hemofiltration solution: 5 Active Agents
Hemofiltration solution: 2 Active Agents | Fresenius Medical
Care (Schweiz) AG | B | FB | G |
| | | IP | | | Multibic 4 mmol/l Kalium | 2 x 5000 ml | | | k.A. | | Hemofiltration solution: 7 Active Agents
Hemofiltration solution: 5 Active Agents
Hemofiltration solution: 2 Active Agents | Fresenius Medical
Care (Schweiz) AG | B | FB | G |
| | | IP | | | Cifoban 136 mmol/l | 8 | | | k.A. | | Infusion solution: Trinatrii Citras Dihydricus | Fresenius Medical
Care (Schweiz) AG | B | FB | G |
| | | IP | | | Cifoban 136 mmol/l | 8 | | | k.A. | | Infusion solution: Trinatrii Citras Dihydricus | Fresenius Medical
Care (Schweiz) AG | B | FB | G |
